Entero Healthcare Solutions (NSE:ENTERO) Loans Receivable: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ENTERO Entero Healthcare Solutions Ltd NSE:ENTERO
65 GF Score
Price ₹1,753.50
GF Value ₹1,746.40
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Entero Healthcare Solutions Loans Receivable?

Entero Healthcare Solutions NSE:ENTERO +6.40% 65 Loans Receivable is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:ENTERO with a GF Score™ of 65/100 and a GF Value™ of ₹1,746.40 (Fairly Valued). The stock has 5 warning signs investors should review.

Entero Healthcare Solutions's Loans Receivable for the quarter that ended in Jun. 2026 was ₹0 Mil.

Entero Healthcare Solutions Loans Receivable Related Terms

Entero Healthcare Solutions Loans Receivable Historical Data

* Premium members only.

The historical data trend for Entero Healthcare Solutions's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entero Healthcare Solutions Loans Receivable Chart

Entero Healthcare Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Loans Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Entero Healthcare Solutions Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:ENTERO
65GF Score
Entero Healthcare Solutions Ltd NSE:ENTERO
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Entero Healthcare Solutions Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of ₹0 Mil mean?
Entero Healthcare Solutions (NSE:ENTERO) has a Loans Receivable of ₹0 Mil as of Jun. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Entero Healthcare Solutions and its competitors.
Is Entero Healthcare Solutions' Loans Receivable too high?
Entero Healthcare Solutions' current Loans Receivable is ₹0 Mil. Overall, Entero Healthcare Solutions has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' Loans Receivable compare to MCK and COR?
Entero Healthcare Solutions' Loans Receivable of ₹0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Medical Distribution company?
A good Loans Receivable depends on the Medical Distribution industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Entero Healthcare Solutions and its competitors. Entero Healthcare Solutions's current Loans Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Based on GuruFocus' analysis, Entero Healthcare Solutions (NSE:ENTERO) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,746.40, compared to a current price of ₹1,753.50 — trading 0.4% above its estimated fair value. The current Loans Receivable is ₹0 Mil. Entero Healthcare Solutions' overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current Loans Receivable is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Entero Healthcare Solutions (NSE:ENTERO) Overvalued in 2026?

Based on GuruFocus' analysis, Entero Healthcare Solutions stock appears to be overvalued. The current stock price of ₹1,753.50 is trading 0.4% above its estimated GF Value™ of ₹1,746.40. GuruFocus considers Entero Healthcare Solutions to be Fairly Valued.

Key valuation signals for NSE:ENTERO:

  • Loans Receivable: ₹0 Mil
  • GF Value™: ₹1,746.40 vs. price of ₹1,753.50 (0.4% above fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the NSE:ENTERO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Entero Healthcare Solutions Business Description

Other Exchanges 544122:India
Address Bandra Kurla Complex, Trade Centre, Unit No. 605 & 606, 6th Floor, Bandra East, Mumbai, MH, IND, 400051
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
65GF Score

Get the complete analysis for NSE:ENTERO

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,753.50
Price
₹1,746.40
GF Value